Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG).

about

Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG).

Item

http://www.wikidata.org/entity/Q38688750

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Lapatinib with whole brain rad ...... rative Oncology Group (HeCOG).

@en

type

Item

label

Lapatinib with whole brain rad ...... rative Oncology Group (HeCOG).

@en

prefLabel

Lapatinib with whole brain rad ...... rative Oncology Group (HeCOG).

@en

P1476

Lapatinib with whole brain rad ...... rative Oncology Group (HeCOG).

@en

P2093

Anna Kalogera-Fountzila

http://www.w3.org/2001/XMLSchema#string

Athina Goudopoulou

http://www.w3.org/2001/XMLSchema#string

Christos N Papandreou

http://www.w3.org/2001/XMLSchema#string

Epaminontas Samantas

http://www.w3.org/2001/XMLSchema#string

Evangelia Razis

http://www.w3.org/2001/XMLSchema#string

George Fountzilas

http://www.w3.org/2001/XMLSchema#string

George Kouvatseas

http://www.w3.org/2001/XMLSchema#string

Georgios Papadopoulos

http://www.w3.org/2001/XMLSchema#string

Grigorios Rallis

http://www.w3.org/2001/XMLSchema#string

Kalliopi Varaki

http://www.w3.org/2001/XMLSchema#string

P2860

Lapatinib plus capecitabine for HER2-positive advanced breast cancer.

Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non-Small-Cell Lung Cancer: Results From PROFILE 1014.

Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomas

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.

The contribution of epidermal growth factor receptor (EGFR) signaling pathway to radioresistance in human gliomas: a review of preclinical and correlative clinical data.

Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study.

Temozolomide for treating brain metastases.

Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study.

Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases

P2888

s11060-017-2548-z

P304

443-451

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-017-2548-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

134

http://www.w3.org/2001/XMLSchema#string

P50

Vasilis Karavasilis

Christos Christodoulou

P577

2017-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090381678

http://www.w3.org/2001/XMLSchema#string

P698

28687923

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy